Both in Pharmaceuticals
Aurinia Pharmaceuticals vs Palvella Therapeutics
Over the past year AUPH returned +22.6% and PVLA returned +90.4%; their daily moves had a correlation of 0.27.
AUPH +22.6% PVLA +90.4%Growth of $1, one year, split-adjusted
| Metric | AUPH | PVLA |
|---|---|---|
| Price | $16.14 | $146.33 |
| Market cap | $2.16B | $2.11B |
| Today | −3.06% | +0.12% |
| 1 month | +2.0% | +10.5% |
| 6 months | +2.3% | +14.7% |
| Year to date | +1.2% | +39.8% |
| 1 year | +33.2% | +86.6% |
| Revenue growth (YoY) | +13.9% | — |
| Gross margin | 90.1% | — |
| Net margin | 37.9% | — |
| P/E (TTM) | 6.9× | — |
| Price / sales | 6.7× | — |
| Net cash | $431.7M | $250.6M |
| Dividend yield | — | — |
| Volatility (60d) | 30.4% | 46.9% |
| Short % of float | 7.3% | 21.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).